Literature DB >> 19411634

GATA-1 associates with and inhibits p53.

Cecelia D Trainor1, Caroline Mas, Patrick Archambault, Paola Di Lello, James G Omichinski.   

Abstract

In addition to orchestrating the expression of all erythroid-specific genes, GATA-1 controls the growth, differentiation, and survival of the erythroid lineage through the regulation of genes that manipulate the cell cycle and apoptosis. The stages of mammalian erythropoiesis include global gene inactivation, nuclear condensation, and enucleation to yield circulating erythrocytes, and some of the genes whose expression are altered by GATA-1 during this process are members of the p53 pathway. In this study, we demonstrate a specific in vitro interaction between the transactivation domain of p53 (p53TAD) and a segment of the GATA-1 DNA-binding domain that includes the carboxyl-terminal zinc-finger domain. We also show by immunoprecipitation that the native GATA-1 and p53 interact in erythroid cells and that activation of p53-responsive promoters in an erythroid cell line can be inhibited by the overexpression of GATA-1. Mutational analysis reveals that GATA-1 inhibition of p53 minimally requires the segment of the GATA-1 DNA-binding domain that interacts with p53TAD. This inhibition is reciprocal, as the activation of a GATA-1-responsive promoter can be inhibited by p53. Based on these findings, we conclude that inhibition of the p53 pathway by GATA-1 may be essential for erythroid cell development and survival.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411634      PMCID: PMC2710945          DOI: 10.1182/blood-2008-10-180489

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Coregulator-dependent facilitation of chromatin occupancy by GATA-1.

Authors:  Saumen Pal; Alan B Cantor; Kirby D Johnson; Tyler B Moran; Meghan E Boyer; Stuart H Orkin; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

2.  Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.

Authors:  D I Martin; S H Orkin
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

3.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

4.  Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter.

Authors:  S F Tsai; E Strauss; S H Orkin
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

5.  An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes.

Authors:  T Evans; M Reitman; G Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

7.  NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1.

Authors:  J G Omichinski; G M Clore; O Schaad; G Felsenfeld; C Trainor; E Appella; S J Stahl; A M Gronenborn
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

8.  Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.

Authors:  S F Tsai; D I Martin; L I Zon; A D D'Andrea; G G Wong; S H Orkin
Journal:  Nature       Date:  1989-06-08       Impact factor: 49.962

9.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.

Authors:  L Pevny; M C Simon; E Robertson; W H Klein; S F Tsai; V D'Agati; S H Orkin; F Costantini
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

10.  Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression.

Authors:  Anna Testa; Francesco Lotti; Linda Cairns; Alexis Grande; Sergio Ottolenghi; Giuliana Ferrari; Antonella Ronchi
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  21 in total

1.  Specific erythroid-lineage defect in mice conditionally deficient for Mediator subunit Med1.

Authors:  Melanie Stumpf; Xiaojing Yue; Sandra Schmitz; Hervé Luche; Janardan K Reddy; Tilman Borggrefe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-23       Impact factor: 11.205

2.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Authors:  Carlos Santamaría; Sandra Muntión; Beatriz Rosón; Belén Blanco; Olga López-Villar; Soraya Carrancio; Fermín M Sánchez-Guijo; María Díez-Campelo; Stela Alvarez-Fernández; María E Sarasquete; Javier de las Rivas; Marcos González; Jesús F San Miguel; María Consuelo Del Cañizo
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

3.  The severe phenotype of Diamond-Blackfan anemia is modulated by heat shock protein 70.

Authors:  Marc Gastou; Sarah Rio; Michaël Dussiot; Narjesse Karboul; Hélène Moniz; Thierry Leblanc; Margaux Sevin; Patrick Gonin; Jérome Larghéro; Carmen Garrido; Anupama Narla; Narla Mohandas; William Vainchenker; Olivier Hermine; Eric Solary; Lydie Da Costa
Journal:  Blood Adv       Date:  2017-10-10

4.  What's in a name?

Authors:  Mitchell J Weiss; Philip J Mason; Monica Bessler
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

Review 5.  Patterns of mutations in TP53 mutated AML.

Authors:  John S Welch
Journal:  Best Pract Res Clin Haematol       Date:  2018-09-20       Impact factor: 3.020

6.  Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.

Authors:  Inga Peters; Natalia Dubrowinskaja; Hossein Tezval; Mario W Kramer; Christoph A von Klot; Jörg Hennenlotter; Arnulf Stenzl; Ralph Scherer; Markus A Kuczyk; Jürgen Serth
Journal:  Target Oncol       Date:  2014-09-19       Impact factor: 4.493

7.  TNF-mediated inflammation represses GATA1 and activates p38 MAP kinase in RPS19-deficient hematopoietic progenitors.

Authors:  Elena Bibikova; Min-Young Youn; Nadia Danilova; Yukako Ono-Uruga; Yoan Konto-Ghiorghi; Rachel Ochoa; Anupama Narla; Bertil Glader; Shuo Lin; Kathleen M Sakamoto
Journal:  Blood       Date:  2014-09-30       Impact factor: 22.113

8.  The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.

Authors:  T Michael Creed; Rajkumar Baldeosingh; Christian L Eberly; Caroline S Schlee; MinJung Kim; Jevon A Cutler; Akhilesh Pandey; Curt I Civin; Nancy G Fossett; Tami J Kingsbury
Journal:  Development       Date:  2020-01-03       Impact factor: 6.868

9.  Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death.

Authors:  Satoru Kobayashi; Paul Volden; Derek Timm; Kai Mao; Xianmin Xu; Qiangrong Liang
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

10.  GATA2-induced silencing and LIM-homeodomain protein-induced activation are mediated by a bi-functional response element in the rat GnRH receptor gene.

Authors:  Anne-Laure Schang; Anne Granger; Bruno Quérat; Christian Bleux; Joëlle Cohen-Tannoudji; Jean-Noël Laverrière
Journal:  Mol Endocrinol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.